FDA
approval
· 2023-10-20
FDA Approved: CABTREO — Original Application (Bausch Health US LLC)
Summary
FDA approves CABTREO, a triple-combination topical acne medication containing clindamycin phosphate, benzoyl peroxide, and adapalene, for the treatment of acne …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CABTREO (CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE)